217 related articles for article (PubMed ID: 28345002)
1. CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman's Syndrome.
Sahin Ersoy G; Zolbin MM; Cosar E; Moridi I; Mamillapalli R; Taylor HS
Mol Ther Methods Clin Dev; 2017 Mar; 4():169-177. PubMed ID: 28345002
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow-Derived Stem Cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome.
Alawadhi F; Du H; Cakmak H; Taylor HS
PLoS One; 2014; 9(5):e96662. PubMed ID: 24819371
[TBL] [Abstract][Full Text] [Related]
3. A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman's syndrome after uterine artery embolization or surgical trauma.
Song D; Liu Y; Xiao Y; Li TC; Zhou F; Xia E
J Minim Invasive Gynecol; 2014; 21(6):1022-8. PubMed ID: 24842805
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic adhesiolysis for patients with Asherman's syndrome: menstrual and fertility outcomes.
Yamamoto N; Takeuchi R; Izuchi D; Yuge N; Miyazaki M; Yasunaga M; Egashira K; Ueoka Y; Inoue Y
Reprod Med Biol; 2013 Oct; 12(4):159-166. PubMed ID: 29662367
[TBL] [Abstract][Full Text] [Related]
5. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study.
Santamaria X; Cabanillas S; Cervelló I; Arbona C; Raga F; Ferro J; Palmero J; Remohí J; Pellicer A; Simón C
Hum Reprod; 2016 May; 31(5):1087-96. PubMed ID: 27005892
[TBL] [Abstract][Full Text] [Related]
6. Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies.
Hou X; Liu Y; Streuli I; Dällenbach P; Dubuisson J; Ansaldi Y; Pluchino N
Curr Stem Cell Res Ther; 2019; 14(6):454-459. PubMed ID: 30760192
[TBL] [Abstract][Full Text] [Related]
7. Asherman's syndrome: a critique and current review.
Klein SM; García CR
Fertil Steril; 1973 Sep; 24(9):722-35. PubMed ID: 4725610
[TBL] [Abstract][Full Text] [Related]
8. Perivascular Stem Cell-Derived Cyclophilin A Improves Uterine Environment with Asherman's Syndrome via HIF1α-Dependent Angiogenesis.
Park M; Hong SH; Park SH; Kim YS; Yang SC; Kim HR; Noh S; Na S; Lee HK; Lim HJ; Lyu SW; Song H
Mol Ther; 2020 Aug; 28(8):1818-1832. PubMed ID: 32534604
[TBL] [Abstract][Full Text] [Related]
9. Effects of uterus derived mesenchymal stem cells and their exosomes on asherman's syndrome.
Saribas GS; Ozogul C; Tiryaki M; Alpaslan Pinarli F; Hamdemir Kilic S
Acta Histochem; 2020 Jan; 122(1):151465. PubMed ID: 31776004
[TBL] [Abstract][Full Text] [Related]
10. Role of hyaluronic acid intrauterine injection in the prevention of Asherman's syndrome in women undergoing uterine septum resection: An RCT.
Tafti SZG; Javaheri A; Firoozabadi RD; Ashkezar SK; Abarghouei HF
Int J Reprod Biomed; 2021 Apr; 19(4):339-346. PubMed ID: 33997593
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of bone marrow-derived cells leads to better uterine engraftment than use of uterine-derived cells or local injection.
Liu Y; Tal R; Pluchino N; Mamillapalli R; Taylor HS
J Cell Mol Med; 2018 Jan; 22(1):67-76. PubMed ID: 28782281
[TBL] [Abstract][Full Text] [Related]
12. [Future reproductive ability in post-treatment Asherman's syndrome patients].
Cruz Orozco OP; Castellanos Barroso G; Gaviño Gaviño F; De la Jara Díaz J; García Vargas J; Roque Sánchez AM
Ginecol Obstet Mex; 2012 Jun; 80(6):389-93. PubMed ID: 22826966
[TBL] [Abstract][Full Text] [Related]
13. Placenta Accreta following Hysteroscopic Lysis of Adhesions Caused by Asherman's Syndrome: A Case Report and Literature Review.
Sonan Y; Aoki S; Enomoto K; Seki K; Miyagi E
Case Rep Obstet Gynecol; 2018; 2018():6968382. PubMed ID: 29955406
[TBL] [Abstract][Full Text] [Related]
14. Reproductive Outcome of Patients with Asherman's Syndrome: A SAIMS Experience.
Bhandari S; Bhave P; Ganguly I; Baxi A; Agarwal P
J Reprod Infertil; 2015; 16(4):229-35. PubMed ID: 27110522
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine Infusion of Human Platelet-Rich Plasma Improves Endometrial Regeneration and Pregnancy Outcomes in a Murine Model of Asherman's Syndrome.
Kim JH; Park M; Paek JY; Lee WS; Song H; Lyu SW
Front Physiol; 2020; 11():105. PubMed ID: 32116803
[TBL] [Abstract][Full Text] [Related]
16. Detection of Asherman's syndrome after conservative management of placenta accreta: a case report.
Chikazawa K; Imai K; Liangcheng W; Sasaki S; Horiuchi I; Kuwata T; Takagi K
J Med Case Rep; 2018 Nov; 12(1):344. PubMed ID: 30454053
[TBL] [Abstract][Full Text] [Related]
17. Making More Womb: Clinical Perspectives Supporting the Development and Utilization of Mesenchymal Stem Cell Therapy for Endometrial Regeneration and Infertility.
Strug M; Aghajanova L
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945836
[TBL] [Abstract][Full Text] [Related]
18. A 10-year Review of the Clinical Presentation and Treatment Outcome of Asherman's Syndrome at a Center with Limited Resources.
Takai IU; Kwayabura AS; Ugwa EA; Idrissa A; Obed JY; Bukar M
Ann Med Health Sci Res; 2015; 5(6):442-6. PubMed ID: 27057384
[TBL] [Abstract][Full Text] [Related]
19. Treatment of minimal and moderate intrauterine adhesions (Asherman's syndrome).
Ismajovich B; Lidor A; Confino E; David MP
J Reprod Med; 1985 Oct; 30(10):769-72. PubMed ID: 4067948
[TBL] [Abstract][Full Text] [Related]
20. Curettage and Asherman's syndrome-lessons to (re-) learn?
Gilman Barber AR; Rhone SA; Fluker MR
J Obstet Gynaecol Can; 2014 Nov; 36(11):997-1001. PubMed ID: 25574677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
